Abstract
Plasma membrane Ca2+-ATPases (PMCAs) are key regulators of global Ca2+ homeostasis and local intracellular Ca2+ dynamics. Recently, Neuroplastin (NPTN) and basigin were identified as previously unrecognized obligatory subunits of PMCAs that dramatically increase the efficiency of PMCA-mediated Ca2+ clearance. Here, we report the cryo-EM structure of human PMCA1 (hPMCA1) in complex with NPTN at a resolution of 4.1 Å for the overall structure and 3.9 Å for the transmembrane domain. The single transmembrane helix of NPTN interacts with the TM8-9-linker and TM10 of hPMCA1. The subunits are required for the hPMCA1 functional activity. The NPTN-bound hPMCA1 closely resembles the E1-Mg2+ structure of endo(sarco)plasmic reticulum Ca2+ ATPase and the Ca2+ site is exposed through a large open cytoplasmic pathway. This structure provides insight into how the subunits bind to the PMCAs and serves as an important basis for understanding the functional mechanisms of this essential calcium pump family.
The plasma membrane Ca2+ ATPase (PMCA) is essential for maintaining Ca2+ homeostasis in eukaryotic cells, and neuroplastin (NPTN) was recently identified as an obligatory subunit of PMCA. Here the authors present the cryo-EM structure of NPTN bound to human PMCA1, which reveals that the NPTN transmembrane (TM) helix interacts with TM10 and the TM8-9-linker of PMCA1.
Introduction
Tight regulation of Ca2+ signaling is crucial for cell function and survival. The plasma membrane Ca2+ ATPase (PMCA) plays an essential role to regulate cellular Ca2+ homeostasis in all eukaryotic cells. PMCA extrudes excess Ca2+ from the cytoplasm, a process that maintains a steep gradient between intracellular (~100 nM) and extracellular Ca2+ (~2 mM)1,2. In nonexcitable cells where the resting-state Ca2+ concentration remains low, PMCA is generally the principal Ca2+ clearance system3,4; In excitable cells such as myocytes and neurons with higher demand for Ca2+ clearance, PMCA cooperates with the sodium/calcium exchanger (NCX) and endo(sarco)plasmic reticulum Ca2+ ATPase (SERCA) in the global maintenance of cellular Ca2+ homeostasis5,6. In addition, the importance of PMCA in the regulation of local intracellular Ca2+ dynamics has steadily increased. It generates a microdomain in its vicinity with low Ca2+ concentration, thereby negatively regulating Ca2+-dependent interaction partners by attracting them to its locale in caveolae7. Genetic deletion or loss-of-function mutations of individual PMCAs are associated with a variety of human diseases, including cardiovascular disease, cerebellar ataxia, deafness, paraplegia, and infertility7–10.
PMCA belongs to the family of P-type ATPases. Three Ca2+-ATPases were identified in animal cells, the class PIIA SERCAs and golgi secretory pathway Ca2+-ATPases (SPCAs), and the class PIIB PMCAs6. Although they share essential properties of membrane topology and working mechanism, PMCAs have some unique properties distinct from the other two Ca2+-ATPases, particularly in the regulation regions. PMCAs have a unique autoinhibitory domain at N terminus (in plants) or C terminus (in mammals)11–14. The action of this domain can be suppressed by directly binding to calmodulin (CaM) or acidic phospholipids15,16. In addition, an additional phospholipid-binding domain that contains about 40 predominantly basic amino acids exists in the first cytosolic loop of mammalian PMCAs, providing the second binding site for acidic phospholipids17. Recently, two immunoglobulin (Ig) superfamily proteins, neuroplastin (NPTN) and basigin (BASI), were identified as previously unrecognized obligatory subunits of PMCAs and essential for the efficient control of the PMCA-mediated Ca2+ clearance10,18,19. However, detailed structural information is unavailable for NPTN- or BASI-bound PMCAs and the molecular mechanism underlying the active effect of the subunits on PMCAs.
Due to their physiological and pathological significance and identification as novel complexes with NPTN and BASI, PMCAs represent important targets for structural characterization. In this manuscript, we report the cryo-electron microscopy (cryo-EM) structure of the human PMCA1 in complex with NPTN at an average resolution of 4.1 Å, with the local resolution at the transmembrane region of the complex reaching 3.9 Å. This structure offers important insight into how the NPTN binds to the PMCA1 and serves as a molecular framework for the mechanistic understanding of the efficient control of PMCA-mediated Ca2+ clearance by NPTN.
Results
Structure determination of the human PMCA1–NPTN complex
To obtain structural information on PMCAs, full-length human PMCA1d (hereinafter referred to as hPMCA1) was successfully overexpressed in mammalian HEK293F cells by transient transfection. Surprisingly, certain smear bands with molecular weights of approximately 55 kDa co-migrated with hPMCA1 on size-exclusion chromatography (Supplementary Fig. 1a). An analysis of 2D class averages showed that an additional density that does not belong to hPMCA1 is present at the extracellular side (Supplementary Fig. 1b), suggesting that hPMCA1 is complexed with an endogenous glycosylated protein. Mass spectrometric (MS) analyses of the additional bands identified both NPTN and BASI (Supplementary Table 1). As a method for isolating hPMCA1-NPTN from hPMCA1-BASI is not available, the density of the subunit in our structure may belong to both NPTN and BASI. We proceeded with cryo-electron microscopy (cryo-EM) analysis under the assumption that the high sequence conservation of the two proteins could be used to resolve the structure of most of the functional elements. Fortunately, the functional residues discussed in this study are invariant between the two proteins. For descriptive purposes, we will refer to this structural complex as NPTN in the remainder of this work.
The reconstruction shows an hPMCA1 molecule associated with an NPTN molecule in our structure. The overall resolution of the EM map is calculated to 4.1 Å using 105,118 selected particles according to the gold-standard Fourier shell correlation (FSC) 0.143 criterion (Fig. 1a, b, Supplementary Table 2, and Supplementary Fig. 2). The EM map is well resolved for most of the P domain and the transmembrane domain, where the local resolution reaches 3.9 Å (Fig. 1a). The main chain of these regions was built by homology modeling based on the crystal structure of SERCA (PDB: 3W5B) and the side chains were assigned mainly by bulky residues such as Phe, Tyr, Trp, and Arg (Supplementary Fig. 4a). The densities for the A domain and the N domain were of lower resolutions. Predicted structures for these two domains generated in Phyre220 can be docked into the map with minor adjustment (Fig. 1a and Supplementary Fig. 4b). In a low-pass-filtered EM map at 6.0 Å resolution, the orientation of the Ig-domain 2 (Ig-2) can be reliably determined, thereby allowing for docking of the crystal structure of the Ig-2 into the map (Supplementary Fig. 4c). However, the density of the Ig-1 is largely missing. In this paper, the structural elucidation is mainly focused on the transmembrane domain with high resolution.
The NPTN-TM interacts with the TM8-9-linker and TM10
The domain organization of hPMCA1 closely resembles that of other P-type ATPases and consists of three large cytoplasmic domains (A, actuator; N, nucleotide binding; P, phosphorylation) and ten transmembrane helices (TM1-10) (Fig. 1c). The C-terminal autoinhibitory domain and the phospholipid-binding domain17 in the first cytosolic loop of the PMCAs are not resolved, suggesting structural flexibility in these regions. The NPTN subunit resembles a gun wherein the TM and Ig-domains form the handle and barrel, respectively (Supplementary Fig. 4c). The NPTN-TM traverses the membrane with a tilt angle of approximately 30° (Fig. 1c). It is positioned adjacent to the TM10 and far from the TM1-9 transmembrane helices of hPMCA1. The NPTN-TM and TM10 of hPMCA1 show intimate interactions through a number of hydrophobic residues near the extracellular surface of the membrane and are far away from each other at the intracellular end. The TM8-9-linker serves as an anchor that stabilizes the interaction (Fig. 2a and Supplementary Fig. 5a). These contact residues are invariant between NPTN and BASI, suggesting that these two proteins share the same binding surface with PMCAs (Fig. 2b). The TM7-8-linker of hPMCA1 may be responsible for the binding to Ig-2 of NPTN (Supplementary Fig. 5b).
To our knowledge, the binding surface shown here is unique among the known interactions of P-type ATPases with their subunits and modulators. Previous structural information on multi-subunit P-type ATPases was obtained in studies of the Na+, K+-ATPase β and γ subunits21 and the H+, K+-ATPase β subunit22,23. The β subunits of these ATPases make direct contact with TM7 and TM10, and the γ-subunit is next to TM9. Similarly, the accessory regulatory protein FXYD10 also interacts almost exclusively with TM924 (Fig. 2c). Additional structural information on the interaction of P-type ATPases with their modulators was obtained from studies of the SERCA-SLN (sarcolipin) complex25,26. SLN was shown to associate with SERCA through a groove surrounded by TM2, TM6, and TM9 (Fig. 2d). Taken together, the hPMCA1–NPTN complex structure represents a novel binding pattern between P-type ATPases and their subunits or modulators.
It has been reported that the NPTN–PMCA interaction was sensitive to solubilization conditions10. To investigate the role of the subunits in the regulation of the hPMCA1 functional activity, detergent screening was performed during the purification to obtain the hPMCA1 alone proteins. The complex was dissociated by washing with dodecyltrimethylammonium chloride (DTAC)-containing buffer (Fig. 2e). Most of the hPMCA1 alone proteins were still well folded (Supplementary Fig. 6). Accordingly, the ATPase activities of purified hPMCA1-NPTN and hPMCA1 alone proteins were examined. The Km and Vmax for the ATPase activity of hPMCA1-NPTN proteins were measured to be ~519.5 µM and ~ 325.5 nmol mg−1 min−1, respectively. The hPMCA1 alone proteins were devoid of ATPase activity (Fig. 2f). These results indicate that the hPMCA1-NPTN proteins are functional and the subunits are required for the hPMCA1 functional activity.
The hPMCA1 closely resembles the E1-Mg2+ structure
The E2-E1 equilibrium of PMCAs is shifted more towards the E2 conformation in the presence of EDTA2. To trap the protein in the autoinhibited state, 5 mM EDTA was added to the buffer in the last step of purification. However, the structure of the NPTN-bound calcium pump differs from the E2 conformation of SERCA (root mean squared deviation (r.m.s.d.) ~7.5 Å) and more closely resembles the E1-Mg2+ conformation (r.m.s.d. ~3.0 Å) (Fig. 3a). The TM1 is sharply bent in hPMCA1, very similar to that in E1-Mg2+ structure; the TM2, TM3, TM5, TM6, TM8, and TM9 in hPMCA1 are well aligned with those in E1-Mg2+ structure. Conspicuous differences are observed in TM1, TM4, TM7, and TM10. To facilitate the binding of NPTN-TM, TM7, and TM10 show dramatic movement towards NPTN-TM. The region near the extracellular ends of TM1 and TM4 also shows obvious movement towards TM2 that may be induced by the rearrangement of the Ca2+-binding pocket (Fig. 3b). When the two structures are superimposed in the transmembrane domain, each of the three cytoplasmic domains shows obvious global movement compared with its position in the E1-Mg2+ conformation (Fig. 3c). These results indicate that the structure of NPTN-bound hPMCA1 closely resembles the E1-Mg2+ structure of SERCA.
Ca2+-binding site and access channel
Compared with the E1-2Ca2+ structure, the Ca2+-binding site of hPMCA1 is formed by E433 in TM4 and by D895, N891 in TM6, and this site is highly conserved with the Ca2+-binding site II. The Ca2+-binding site I is not preserved in PMCAs due to substitution of the essential acidic residue E771 in TM5 and E908 in TM8 of SERCA by A866 and Q983 in hPMCA1 (Fig. 4a, b), respectively. Similar to the E1-Mg2+ conformation of SERCA, a large open mouth was formed by the TM1 kink, TM2, TM3, and TM4 near the cytoplasmic surface of the membrane extends towards the transmembrane Ca2+-binding site (Fig. 4c). The electrostatic potential surface shows that the Ca2+ permeation pathway is funnel shaped and consists of a large cytosolic vestibule leading to a narrow transmembrane tunnel. Numerous negatively charged residues (E104, D108, D174, and E178) are present in the funnel, thereby contributing to cation selectivity (Fig. 4d). Accordingly, the E1-NPTN structure shown here represents an E1-Mg2+-like intermediate conformation between E2 and E1-Ca2+; in this conformation, the Ca2+-binding site is exposed to the cytoplasm and ready to accept new cytosolic Ca2+.
TM1 sliding door of hPMCA1
A TM1 sliding door in SERCA and Na+, K+-ATPase control the exposure of the cation-binding site to the cytoplasm25,27. For instance, the TM1 of SERCA is sharply bent as a TM1 kink, with the hydrophobic residue L61 of TM1 and the small residue G257 of TM3 serving as pivot points. The conserved L65 of TM1 functions as a gate-lock residue that restricts the mobility of the side chain of E309 in TM4, a key residue for Ca2+ binding and release. Compared with the E2 state of SERCA, T110 of TM1 and A370 of TM3 serve as pivot points for the kink in hPMCA1, whereas L114 restricts the mobility of E433. Notably, compared with the SERCA(E2) conformation, the TM1’ of hPMCA1-NPTN occupies a significantly higher position with respect to the membrane. The distance between the Cα atoms of T110 in hPMCA1-NPTN and L61 in SERCA(E2) can be as high as 11 Å, indicating that significant movement of the TM1 sliding door in E1-NPTN occurs to expose the Ca2+-binding site (Fig. 5a). The position of the TM1 kink is similar to that observed in the E1-Mg2+ state of SERCA, in which T110 faces L427 of TM4 and L114 associates with V424 of TM4. In the E2 state of SERCA, in which the Ca2+ entry pathway is blocked, the distance between the Cα atoms of G257 and L61 is 6 Å. Correspondingly, the distance between the Cα atoms of A370 and T110 in hPMCA1-NPTN increases to 16 Å (Fig. 5a, b). Accordingly, the Ca2+ entry pathway becomes accessible. A cartoon is presented in Fig. 5c to illustrate the exposure of the Ca2+-binding site through sliding of TM1 during the transition from the E2 state to the E1 state.
Discussion
P-type ATPases are fundamental in establishing and maintaining steep gradients of key cations across membranes. The P-type ATPase superfamily encompasses 11 distinct classes, covering a wide range of cationic and lipid substrates28,29. Members of the class PIIC (Na+, K+-ATPase and H+, K+-ATPase) and most of the PIV subfamily ATPases form a heterocomplex with at least one additional subunit, which is essential for function30. Only recently, the class PIIB PMCAs were identified as heteromeric complexes that are assembled from two ATPases and two essential auxiliary subunits, either NPTN or BASI10, instead of being monomers or homodimers as previously envisaged9,15,31. Atomic structures of P-type ATPases have been determined for the class PIB copper-transporting ATPase32 and zinc-transporting ATPase33, the class PIIA SERCA34, the class PIIC Na+, K+-ATPase21 and H+, K+-ATPase23, and the class PIIIA H+-ATPase35. In this manuscript, the structure of a PIIB Ca2+-ATPase in complex with its obligatory subunit marks an important step towards understanding the functional mechanisms of this essential calcium pump family.
Our structure offers the first picture on the molecular appearance of PMCAs. The reconstruction shows an hPMCA1 molecule associated with an NPTN molecule in our structure (Fig. 1). The native PMCAs are assembled as heterotetramers of two ATPase subunits and two NPTN or BASI molecules10, suggesting that the quaternary complex may be dissociated in the detergent environment. Interestingly, the hPMCA1 alone proteins were devoid of ATPase activity (Fig. 2f). It has been reported that the PMCA-mediated Ca2+ transport was largely abolished in the NPTN/BASI double knockout cells, an effect comparable with that of washout of ATP10. Transient expression of PMCA2 led to only partial restoration of Ca2+ transport, indicating that Ca2+ may be transported by PMCA2 alone in vivo10. A possible explanation for this difference is that the lipids in the plasma membrane play important roles in regulating the activity of PMCAs36.
The residues 206–271 (A domain) and 537–544 (N domain) of hPMCA4 serve as two receptor sites for interacting with the CaM-binding sites (CaM-BS) of autoinhibitory domain11,12. The access of proteases to their cleavage sites near the CaM-BS was used as a measure of regulatory interaction in PMCAs. The cleavage sites are completely protected in the presence of EDTA, indicating that the CaM-BS tightly interacts with the receptor sites and the E2-E1 equilibrium is shifted more toward the E2 conformation2. The structure of NPTN-bound hPMCA1 closely resembles the E1-Mg2+ intermediate even in the presence of EDTA (Fig. 3), with exposure of the Ca2+ site through an open cytoplasmic pathway (Fig. 4c, d), indicating that the NPTN may improve the efficiency of PMCA-mediated Ca2+ transport by facilitating the transition of hPMCA1 from E2 to E1 conformation.
However, the molecular mechanism for the transition from the E1-NPTN state to the autoinhibited state remains unknown. As the NPTN is required for the hPMCA1 functional activity (Fig. 2f), we speculate that the transition may be accompanied by the dissociation of subunits from the PMCAs in the plasma membrane. Nevertheless, there is a possibility that, lipids of plasma membrane could influence this process in native environment. The PMCA activity is influenced by the phospholipid composition in the surrounding plasma membrane36,37. Acidic phospholipids and polyunsaturated fatty acids activate the pump by binding to two sites in the pump: one is the CaM-BS17, the other is the phospholipid-binding domain in the cytosolic loop that connects TM2 and TM338. Structure analysis indicates that the phospholipid-binding domain is located in the vicinity of the large cytosolic vestibule of Ca2+ permeation pathway (Supplementary Fig. 7), suggesting that the phospholipid-binding domain may directly affect the Ca2+ access channel by interacting with acidic phospholipids. The concentration of the doubly phosphorylated derivative of phosphatidyl inositol (PIP2), the most effective acidic phospholipid in stimulating PMCA activity, is modulated during Ca2+-related signaling processes. Accordingly, a possible PIP2-mediated reversible PMCA inactivation mechanism could be envisaged6,39. Structures of PMCAs in more conformations during the transport cycle are necessary to fully understand the regulatory mechanisms of the subunits and the autoinhibitory domain on PMCAs.
The structure of the hPMCA1–NPTN complex will facilitate future investigation on the pathogenic mechanism of mutations on PMCAs. The genome-wide association studies in recent years have suggested potential significance of PMCAs in human health and diseases7. A number of point mutations on PMCAs have been associated with phenotypes in human and mouse40–47. Among the identified mutations, 5 out of 7 mutations on PMCA2, 1 out of 3 on PMCA3, and one on PMCA4 can be reliably mapped to the structure (Supplementary Figs. 3 and 8). In sum, our structural analysis provides an important framework for the elucidation of the function and disease mechanism of this essential calcium pump family.
Methods
Expression and purification of human PMCA1
The complementary DNA of full-length hPMCA1d was subcloned into the pCAG vector (Supplementary Table 3). A C-terminal FLAG tag and a C-terminal His8 tag were fused for two-step purification. HEK293F cells (Invitrogen) were cultured in SMM 293T-I medium (Sino Biological Inc.) at 37 °C under 5% CO2 in a Multitron-Pro shaker (Infors, 130 rpm). When the cell density reached 2.0 × 106 cells per ml, the pCAG-PMCA1 plasmids were transiently transfected into the cells. For one-litre cell cultures, approximately 1.5 mg of plasmid was pre-mixed with 4.0 mg 25-kDa linear polyethylenimines (PEIs) (Polysciences) in 50 ml fresh medium for 20–30 min before transfection. The 50 ml mixture was then added to the cell culture, and the culture was incubated for 30 min for transfection. The transfected cells were cultured for 48 h before harvesting.
For purification of hPMCA1, 12 l of cells were collected and resuspended in lysis buffer containing 25 mM Tris pH 8.0, 150 mM NaCl, 1.3 µg/ml aprotinin, 1 µg/ml pepstatin, 5 µg/ml leupeptin, and 0.2 mM PMSF (lysis buffer A). The membrane fraction was solubilized at 4 °C for 2 h in 1% (w/v) N-dodecyl β-d-maltoside (DDM) and 0.2% (w/v) cholesterol hemisuccinate (CHS). After centrifugation at 25,000 х g for 40 min at 4 °C, the supernatant was passed over an anti-FLAG M2 affinity gel (Sigma) column twice. The resin was washed three times with 10 ml wash buffer A (lysis buffer A plus 0.02% DDM and 0.004% CHS). The protein was eluted with elution buffer A (wash buffer A plus 200 µg/ml FLAG peptide (Sigma)). The eluent was incubated with nickel affinity resin (Ni-NTA, Qiagen) at 4 °C for 40 min, the resin was washed with wash buffer B (lysis buffer A plus 0.1% (w/v) digitonin (Sigma) and 10 mM imidazole), and the protein was eluted with elution buffer B (lysis buffer A plus 0.1% digitonin and 300 mM imidazole). The eluent was concentrated with a 100-kDa cutoff Centricon (Millipore) and subjected to size-exclusion chromatography (SEC, Superose 6, 10/300, GE Healthcare) in a buffer containing 25 mM Tris pH 8.0, 150 mM NaCl, 1.3 µg/ml aprotinin, 1 µg/ml pepstatin, 5 µg/ml leupeptin, 0.2 mM PMSF, 0.1% digitonin, 2 mM DTT, and 5 mM EDTA. For the cryo-EM analysis, the peak fractions were concentrated to ~8 mg/ml by a 100-kDa cutoff Centricon.
To obtain the hPMCA1 alone proteins, detergent screening was performed during purification. The hPMCA1-NPTN proteins used for ATPase activity assay were purified as mentioned above. The hPMCA1 alone proteins were purified similarly, except that DDM was replaced by different detergents in washing and elution steps of the first-step purification and Superose 6 column was replaced by Superdex 200 column in the last step purification. The subunit BASI was detected by the anti-BASI antibodies (R&D Systems).
Sample preparation and cryo-EM data acquisition
Vitrobot Mark IV (FEI) was used in the preparation of the cryo-EM grids. Aliquots (3 µl each) of hPMCA1-NPTN protein were placed on glow-discharged Quantifoil (1.2/1.3) 300 mesh Au grids (Zhongjingkeyi Technology Co. Ltd.). The grids were blotted for 4 s and plunged into liquid ethane cooled with liquid nitrogen. The grids were then transferred to a Titan Krios (FEI) electron microscope equipped with a Gatan GIF Quantum energy filter and operated at 300 kV with a nominal magnification of 105,000×. Zero-loss movie stacks were automatically collected using AutoEMationII48,49 with a slit width of 20 eV on the energy filter and a defocus range from –1.5 μm to –2.5 μm. Each stack was exposed in super-resolution mode for 5.6 s with an exposure time of 0.175 s per frame, resulting in 32 frames per stack. The total dose was approximately 50 e-/Å2 for each stack. The stacks were first motion-corrected with MotionCorr50 and binned by twofold, resulting in a pixel size of 1.091 Å/pixel. The output stacks from MotionCorr were further motion-corrected with MotionCor251, and dose weighting was performed52. The defocus values were estimated using Gctf53.
Image processing
A diagram of the procedures used in data processing is presented in Supplementary Fig. 2. Approximately 3000 particles were manually picked and used to generate 2D classes for templates for auto-picking. A total of 1,730,910 particles were auto-picked from 4100 micrographs with RELION 2.054. After 2D classification, ten good 2D classes were used to generate an initial model using e2initialmodel.py55, and a total of 1,001,249 good particles were then selected and subjected to 3D auto-refinement. The particles were further subjected to several cycles of 3D classification with six classes and a local angular search step of 3.75° with the output from different global angular search iterations of the 3D auto-refinement as input. The class with fully intact particles was considered as a good class, which contains useful high-resolution information and usually has the smallest value of the accuracy of rotation and translation. A total of non-duplicated 655,998 particles were selected from the good classes of local angular search 3D classification. These particles were subjected to local angular search 3D auto-refinement with a soft mask applied, resulting in a 4.5-Å resolution map. The particles were classified into four classes using multi-reference, and the best classes were selected and combined. The final particle number for the 3D auto-refinement is 105,118, thereby resulting in a 4.1-Å resolution map after post-processing. The resolution was estimated with the gold-standard Fourier shell correlation 0.143 criterion56 with the high-resolution noise substitution method57.
Model building and refinement
The 4.1-Å reconstruction map was used for model building. The structure of E1-Mg2+ (PDB: 3W5B), which was first fitted into the EM map by Chimera, served as a reference for model building. Model building was performed in COOT58. Bulky residues, such as Phe, Tyr, Trp, and Arg, in many of the TMs and in the P domain of hPMCA1 were clearly visible in our cryo-EM structure and used as landmarks for model building. The secondary structure predicted by Phyre220 based on the sequence of the A domain (residues 193–290) was well fitted into the map, and the bulky residues F194, R198, R219, and Y220, which were clearly resolved, and several motifs that are highly conserved between SERCA and PMCAs facilitated the sequence assignment (Supplementary Fig. 3). The structure formed by residues 73–89 of the N terminal region was built based on the structure of SERCA (PDB: 3W5B). Residues 2–72 of the N terminal region were built as poly-Ala due to the lack of homolog structure. The N domain predicted by Phyre2 was fitted into the map and manually adjusted in COOT; however, tracing the main chains of the β-strands was challenging due to the lower resolution. For the NPTN, the bulky residues W225 and F227 in the transmembrane domain were clearly resolved, thereby facilitating the sequence assignment. The Ig-2 of the crystal structure of rabbit NPTN (PDB: 2WV3) was fitted into the low-pass-filtered 6.0-Å resolution map, and the density of glycosylation site N168 was used for model confirmation. Modeling of the Ig-1 failed due to difficulty in determining its orientation at the low-pass-filtered 6.0-Å resolution. Structure refinement was performed by PHENIX59 in real space with a secondary structure and geometry restraints. The statistics of the 3D reconstruction and model refinement are summarized in Supplementary Table 2.
ATPase activity assay
The hPMCA1-NPTN and hPMCA1 alone proteins used for ATPase activity assay were purified as described above. The ATPase activity was measured using QuantiChrom ATPase/GTPase assay kit (BioAssay Systems). The protein concentrations for the assays ranged from 0.05 to 0.2 mg/ml. All reactions were performed using the reaction buffer from the assay kit with final concentration of 1.83 mM CaCl2, 5 mM MgCl2, 1.75 mM EDTA, 0.05% digitonin, 1 mM DTT, and indicated ATP. Reactions were carried out at 37 °C for 10 min and stopped by addition of the reagent from assay kit. The mixture was incubated for 30 min at room temperature before the activity was measured by monitoring the increase of absorbance at 620 nm. Nonlinear regression to the Michaelis-Menten equation and data analysis was performed using OriginPro 8.
Electronic supplementary material
Acknowledgements
We thank Xiaomei Li and Xiaomin Li for technical support at the cryo-EM facility. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the cryo-EM facility support. We thank the computational facility support on the cluster of Bio-Computing Platform (Tsinghua University Branch of China National Center for Protein Sciences Beijing) and the “Explorer 100” cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from National Key Basic Research Program (973 Program) of China (2015CB910101), the National Key R&D Program of China (2016YFA0500402), and the National Natural Science Foundation of China (projects 31621092, 31630017, and 31611130036).
Author contributions
D.G. conceived the project and designed all experiments. D.G., X.C., K.R. and G.Z. performed experiments. D.G., X.C., G.H., J.L. and Q.Z. conducted the cryo-EM analysis. All authors contributed to data analysis. D.G. built the atomic model and wrote the manuscript. N.Y. helped with editing the paper before submission.
Data availability
Atomic coordinate and EM density map of the hPMCA1-NPTN (PDB: 6A69; EMDB: EMD-6987) have been deposited in the Protein Data Bank (http://www.rcsb.org) and the Electron Microscopy Data Bank (https://www.ebi.ac.uk/pdbe/emdb/). Other data are available from the corresponding authors upon reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Deshun Gong, Ximin Chi, Kang Ren.
Contributor Information
Deshun Gong, Email: dsgong@tsinghua.edu.cn.
Qiang Zhou, Email: zhouqiang00@tsinghua.org.cn.
Electronic supplementary material
Supplementary Information accompanies this paper at 10.1038/s41467-018-06075-7.
References
- 1.Clapham DE. Calcium signaling. Cell. 2007;131:1047–1058. doi: 10.1016/j.cell.2007.11.028. [DOI] [PubMed] [Google Scholar]
- 2.Padanyi R, et al. Intramolecular interactions of the regulatory region with the catalytic core in the plasma membrane calcium pump. J. Biol. Chem. 2003;278:35798–35804. doi: 10.1074/jbc.M305794200. [DOI] [PubMed] [Google Scholar]
- 3.Zylinska L, Soszynski M. Plasma membrane Ca2+-ATPase in excitable and nonexcitable cells. Acta Biochim. Pol. 2000;47:529–539. [PubMed] [Google Scholar]
- 4.Muallem S, Beeker T, Pandol SJ. Role of Na+/Ca2+ exchange and the plasma membrane Ca2+ pump in hormone-mediated Ca2+ efflux from pancreatic acini. J. Membr. Biol. 1988;102:153–162. doi: 10.1007/BF01870453. [DOI] [PubMed] [Google Scholar]
- 5.Oceandy D, Stanley PJ, Cartwright EJ, Neyses L. The regulatory function of plasma-membrane Ca2+-ATPase (PMCA) in the heart. Biochem. Soc. Trans. 2007;35:927–930. doi: 10.1042/BST0350927. [DOI] [PubMed] [Google Scholar]
- 6.Brini M, Cali T, Ottolini D, Carafoli E. Calcium pumps: why so many? Compr. Physiol. 2012;2:1045–1060. doi: 10.1002/cphy.c110034. [DOI] [PubMed] [Google Scholar]
- 7.Stafford N, Wilson C, Oceandy D, Neyses L, Cartwright EJ. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol. Rev. 2017;97:1089–1125. doi: 10.1152/physrev.00028.2016. [DOI] [PubMed] [Google Scholar]
- 8.Bortolozzi M, et al. The novel PMCA2 pump mutation Tommy impairs cytosolic calcium clearance in hair cells and links to deafness in mice. J. Biol. Chem. 2010;285:37693–37703. doi: 10.1074/jbc.M110.170092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brini M, Cali T, Ottolini D, Carafoli E. The plasma membrane calcium pump in health and disease. FEBS J. 2013;280:5385–5397. doi: 10.1111/febs.12193. [DOI] [PubMed] [Google Scholar]
- 10.Schmidt N, et al. Neuroplastin and basigin are essential auxiliary subunits of plasma Membrane Ca2+-ATPases and key regulators of Ca2+ clearance. Neuron. 2017;96:827–838. doi: 10.1016/j.neuron.2017.09.038. [DOI] [PubMed] [Google Scholar]
- 11.Falchetto R, Vorherr T, Brunner J, Carafoli E. The plasma membrane Ca2+ pump contains a site that interacts with its calmodulin-binding domain. J. Biol. Chem. 1991;266:2930–2936. [PubMed] [Google Scholar]
- 12.Falchetto R, Vorherr T, Carafoli E. The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme. Protein Sci. 1992;1:1613–1621. doi: 10.1002/pro.5560011209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bonza MC, Luoni L. Plant and animal type 2B Ca2+-ATPases: evidence for a common auto-inhibitory mechanism. FEBS Lett. 2010;584:4783–4788. doi: 10.1016/j.febslet.2010.11.008. [DOI] [PubMed] [Google Scholar]
- 14.Malmstrom S, Askerlund P, Palmgren MG. A calmodulin-stimulated Ca2+-ATPase from plant vacuolar membranes with a putative regulatory domain at its N-terminus. FEBS Lett. 1997;400:324–328. doi: 10.1016/S0014-5793(96)01448-2. [DOI] [PubMed] [Google Scholar]
- 15.Tidow H, et al. A bimodular mechanism of calcium control in eukaryotes. Nature. 2012;491:468–472. doi: 10.1038/nature11539. [DOI] [PubMed] [Google Scholar]
- 16.Bonza MC, Luoni L, De Michelis MI. Stimulation of plant plasma membrane Ca2+-ATPase activity by acidic phospholipids. Physiol. Plant. 2001;112:315–320. doi: 10.1034/j.1399-3054.2001.1120303.x. [DOI] [PubMed] [Google Scholar]
- 17.Brodin P, Falchetto R, Vorherr T, Carafoli E. Identification of two domains which mediate the binding of activating phospholipids to the plasma-membrane Ca2+ pump. Eur. J. Biochem. 1992;204:939–946. doi: 10.1111/j.1432-1033.1992.tb16715.x. [DOI] [PubMed] [Google Scholar]
- 18.Korthals M, et al. A complex of neuroplastin and plasma membrane Ca2+ ATPase controls T cell activation. Sci. Rep. 2017;7:8358. doi: 10.1038/s41598-017-08519-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Herrera-Molina R, et al. Neuroplastin deletion in glutamatergic neurons impairs selective brain functions and calcium regulation: implication for cognitive deterioration. Sci. Rep. 2017;7:7273. doi: 10.1038/s41598-017-07839-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 2015;10:845–858. doi: 10.1038/nprot.2015.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Morth JP, et al. Crystal structure of the sodium-potassium pump. Nature. 2007;450:1043–1049. doi: 10.1038/nature06419. [DOI] [PubMed] [Google Scholar]
- 22.Abe K, Tani K, Friedrich T, Fujiyoshi Y. Cryo-EM structure of gastric H + ,K + -ATPase with a single occupied cation-binding site. Proc. Natl Acad. Sci. USA. 2012;109:18401–18406. doi: 10.1073/pnas.1212294109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Abe K, Irie K, Nakanishi H, Suzuki H, Fujiyoshi Y. Crystal structures of the gastric proton pump. Nature. 2018;556:214–218. doi: 10.1038/s41586-018-0003-8. [DOI] [PubMed] [Google Scholar]
- 24.Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature. 2009;459:446–450. doi: 10.1038/nature07939. [DOI] [PubMed] [Google Scholar]
- 25.Winther AM, et al. The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm. Nature. 2013;495:265–269. doi: 10.1038/nature11900. [DOI] [PubMed] [Google Scholar]
- 26.Toyoshima C, et al. Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state. Nature. 2013;495:260–264. doi: 10.1038/nature11899. [DOI] [PubMed] [Google Scholar]
- 27.Einholm AP, Andersen JP, Vilsen B. Roles of transmembrane segment M1 of Na+,K+-ATPase and Ca2+-ATPase, the gatekeeper and the pivot. J. Bioenerg. Biomembr. 2007;39:357–366. doi: 10.1007/s10863-007-9106-x. [DOI] [PubMed] [Google Scholar]
- 28.Axelsen KB, Palmgren MG. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 1998;46:84–101. doi: 10.1007/PL00006286. [DOI] [PubMed] [Google Scholar]
- 29.Moller AB, Asp T, Holm PB, Palmgren MG. Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps. Mol. Phylogenet. Evol. 2008;46:619–634. doi: 10.1016/j.ympev.2007.10.023. [DOI] [PubMed] [Google Scholar]
- 30.Bublitz M, Poulsen H, Morth JP, Nissen P. In and out of the cation pumps: P-type ATPase structure revisited. Curr. Opin. Struc. Biol. 2010;20:431–439. doi: 10.1016/j.sbi.2010.06.007. [DOI] [PubMed] [Google Scholar]
- 31.Sackett DL, Kosk-Kosicka D. The active species of plasma membrane Ca2+-ATPase are a dimer and a monomer-calmodulin complex. J. Biol. Chem. 1996;271:9987–9991. doi: 10.1074/jbc.271.17.9987. [DOI] [PubMed] [Google Scholar]
- 32.Gourdon P, et al. Crystal structure of a copper-transporting PIB-type ATPase. Nature. 2011;475:59–64. doi: 10.1038/nature10191. [DOI] [PubMed] [Google Scholar]
- 33.Wang K, et al. Structure and mechanism of Zn2+-transporting P-type ATPases. Nature. 2014;514:518–522. doi: 10.1038/nature13618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Toyoshima C, Nakasako M, Nomura H, Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature. 2000;405:647–655. doi: 10.1038/35015017. [DOI] [PubMed] [Google Scholar]
- 35.Pedersen BP, Buch-Pedersen MJ, Morth JP, Palmgren MG, Nissen P. Crystal structure of the plasma membrane proton pump. Nature. 2007;450:1111–1114. doi: 10.1038/nature06417. [DOI] [PubMed] [Google Scholar]
- 36.Tang D, Dean WL, Borchman D, Paterson CA. The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. Cell Calcium. 2006;39:209–216. doi: 10.1016/j.ceca.2005.10.010. [DOI] [PubMed] [Google Scholar]
- 37.Pang Y, Zhu H, Wu P, Chen J. The characterization of plasma membrane Ca2+-ATPase in rich sphingomyelin-cholesterol domains. FEBS Lett. 2005;579:2397–2403. doi: 10.1016/j.febslet.2005.03.038. [DOI] [PubMed] [Google Scholar]
- 38.Zvaritch E, et al. Mapping of functional domains in the plasma membrane Ca2+ pump using trypsin proteolysis. Biochemistry. 1990;29:8070–8076. doi: 10.1021/bi00487a012. [DOI] [PubMed] [Google Scholar]
- 39.Choquette D, et al. Regulation of plasma membrane Ca2+ ATPases by lipids of the phosphatidylinositol cycle. Biochem. Biophys. Res. Commun. 1984;125:908–915. doi: 10.1016/0006-291X(84)91369-X. [DOI] [PubMed] [Google Scholar]
- 40.Brini M, Carafoli E, Cali T. The plasma membrane calcium pumps: focus on the role in (neuro)pathology. Biochem. Biophys. Res. Commun. 2017;483:1116–1124. doi: 10.1016/j.bbrc.2016.07.117. [DOI] [PubMed] [Google Scholar]
- 41.Ho PW, et al. PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion. Brain Behav. 2015;5:e00321. doi: 10.1002/brb3.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cali T, et al. A novel mutation in isoform 3 of the plasma membrane Ca2+ pump impairs cellular Ca2+ homeostasis in a patient with cerebellar ataxia and laminin subunit 1alpha mutations. J. Biol. Chem. 2015;290:16132–16141. doi: 10.1074/jbc.M115.656496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Street VA, McKee-Johnson JW, Fonseca RC, Tempel BL, Noben-Trauth K. Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat. Genet. 1998;19:390–394. doi: 10.1038/1284. [DOI] [PubMed] [Google Scholar]
- 44.Schultz JM, et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. New Engl. J. Med. 2005;352:1557–1564. doi: 10.1056/NEJMoa043899. [DOI] [PubMed] [Google Scholar]
- 45.Takahashi K, Kitamura K. A point mutation in a plasma membrane Ca2+-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem. Biophys. Res. Commun. 1999;261:773–778. doi: 10.1006/bbrc.1999.1102. [DOI] [PubMed] [Google Scholar]
- 46.Tatsuki F, et al. Involvement of Ca2+-dependent hyperpolarization in sleep duration in mammals. Neuron. 2016;90:70–85. doi: 10.1016/j.neuron.2016.02.032. [DOI] [PubMed] [Google Scholar]
- 47.Spiden SL, et al. The novel mouse mutation Oblivion inactivates the PMCA2 pump and causes progressive hearing loss. PLoS Genet. 2008;4:e1000238. doi: 10.1371/journal.pgen.1000238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fan X, et al. Near-atomic resolution structure determination in over-focus with volta phase plate by Cs-corrected Cryo-EM. Structure. 2017;25:1623–1630. doi: 10.1016/j.str.2017.08.008. [DOI] [PubMed] [Google Scholar]
- 49.Lei J, Frank J. Automated acquisition of cryo-electron micrographs for single particle reconstruction on an FEI Tecnai electron microscope. J. Struct. Biol. 2005;150:69–80. doi: 10.1016/j.jsb.2005.01.002. [DOI] [PubMed] [Google Scholar]
- 50.Li X, et al. Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat. Methods. 2013;10:584–590. doi: 10.1038/nmeth.2472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Grant T, Grigorieff N. Measuring the optimal exposure for single particle cryo-EM using a 2.6 A reconstruction of rotavirus VP6. eLife. 2015;4:e06980. doi: 10.7554/eLife.06980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhang K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 2016;193:1–12. doi: 10.1016/j.jsb.2015.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kimanius D, Forsberg BO, Scheres SH, Lindahl E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. eLife. 2016;5:e18722. doi: 10.7554/eLife.18722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Tang G, et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 2007;157:38–46. doi: 10.1016/j.jsb.2006.05.009. [DOI] [PubMed] [Google Scholar]
- 56.Rosenthal PB, Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 2003;333:721–745. doi: 10.1016/j.jmb.2003.07.013. [DOI] [PubMed] [Google Scholar]
- 57.Chen S, et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy. 2013;135:24–35. doi: 10.1016/j.ultramic.2013.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Pettersen EF, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Atomic coordinate and EM density map of the hPMCA1-NPTN (PDB: 6A69; EMDB: EMD-6987) have been deposited in the Protein Data Bank (http://www.rcsb.org) and the Electron Microscopy Data Bank (https://www.ebi.ac.uk/pdbe/emdb/). Other data are available from the corresponding authors upon reasonable request.